2026-2034年全球牛血漿衍生產品市場規模、佔有率、趨勢和成長分析報告

預計牛血漿衍生市場將從 2025 年的 27.6 億美元成長到 2034 年的 46.8 億美元，2026 年至 2034 年的複合年成長率為 6.06%。

由於製藥、營養補充劑和飼料行業的需求不斷成長，全球牛血漿衍生市場正在擴張。這些衍生廣泛應用於細胞培養基、疫苗和蛋白質補充劑。生物技術研究的進步和對高品質生物原料日益成長的需求是推動市場成長的關鍵因素。

在食品和飼料行業，牛血漿衍生物因其功能特性（例如改善質地和蛋白質含量）而備受重視。全球肉類消費量的成長和畜牧健康管理技術的進步進一步推動了市場需求。此外，免疫學和疫苗生產領域的研究活動活性化，也促進了市場的穩定擴張。

受生物技術和生命科學研究領域投資增加的推動，前景依然樂觀。隨著新興市場製藥產能的擴大，預計該技術將更廣泛應用。血漿分餾技術的持續創新和品質標準的提升將進一步拓展全球市場機會。

目錄

第1章：引言

第2章執行摘要

第3章 市場變數、趨勢與框架

• 市場譜系展望
• 滲透率和成長前景分析
• 價值鏈分析
• 法律規範
  • 標準與合規性
  • 監管影響分析
• 市場動態
  • 市場促進因素
  • 市場限制因素
  • 市場機遇
  • 市場挑戰
• 波特五力分析
• PESTLE分析

第4章：全球牛血漿衍生產品市場：依產品分類

• 市場分析、洞察與預測
• 試劑盒和試劑
• 裝置
• 軟體和服務

第5章 全球牛血漿衍生產品市場：依技術分類

• 市場分析、洞察與預測
• 分子診斷
• 血液學
• 免疫診斷
• 其他（細胞培養等）

第6章：全球牛血漿衍生產品市場：依衍生產品類型分類

• 市場分析、洞察與預測
• 免疫球蛋白
• 纖維蛋白原
• 血清白蛋白
• 牛
• 長號
• 轉鐵蛋白
• 其他（BGG 等）

第7章 全球牛血漿衍生產品市場：依來源分類

• 市場分析、洞察與預測
• 美國標準
• 澳洲等級
• 紐西蘭等級
• 其他

第8章：全球牛血漿衍生產品市場：依終端用戶產業分類

• 市場分析、洞察與預測
• 獸醫業
• 食品工業
• 學術研究機構
• 細胞培養/生物技術
• 化妝品產業
• 製藥業
• 診斷產業
• 其他（營養補充品、合約研究組織等）

第9章 全球牛血漿衍生產品市場：按地區分類

• 區域分析
• 北美市場分析、洞察與預測
  • 美國
  • 加拿大
  • 墨西哥
• 歐洲市場分析、洞察與預測
  • 英國
  • 法國
  • 德國
  • 義大利
  • 俄羅斯
  • 其他歐洲國家
• 亞太市場分析、洞察與預測
  • 印度
  • 日本
  • 韓國
  • 澳洲
  • 東南亞
  • 其他亞太國家
• 拉丁美洲市場分析、洞察與預測
  • 巴西
  • 阿根廷
  • 秘魯
  • 智利
  • 其他拉丁美洲國家
• 中東和非洲市場分析、洞察與預測
  • 沙烏地阿拉伯
  • UAE
  • 以色列
  • 南非
  • 其他中東和非洲國家

第10章 競爭格局

• 最新趨勢
• 公司分類
• 供應鏈和銷售管道合作夥伴（根據現有資訊）
• 市場佔有率和市場定位分析（基於現有資訊）
• 供應商情況（基於現有資訊）
• 策略規劃

第11章：公司簡介

• 主要公司的市佔率分析
• 公司簡介
  • ANZCO Foods（Itoham Yonekyu Holdings）
  • Bovogen Biologicals Pty Ltd（ANZCO Foods Healthcare）
  • Moregate Biotech（ANZCO Foods）
  • Proliant Health & Biologicals
  • LAMPIRE Biological Laboratories Inc
  • Rocky Mountain Biologicals
  • Thermo Fisher Scientific Inc
  • Sigma-Aldrich（Merck KGaA）
  • Kraeber & Co GmbH
  • Auckland BioSciences Ltd
  • Lake Immunogenics Inc

The Bovine Blood Plasma Derivatives Market size is expected to reach USD 4.68 Billion in 2034 from USD 2.76 Billion (2025) growing at a CAGR of 6.06% during 2026-2034.

The global bovine blood plasma derivatives market is expanding due to increasing demand from the pharmaceutical, nutraceutical, and animal feed industries. These derivatives are widely used in cell culture media, vaccines, and protein supplements. Growing biotechnology research and the rising need for high-quality biological ingredients are key drivers supporting market growth.

In the food and feed industry, bovine plasma derivatives are valued for their functional properties, such as improving texture and protein content. Rising global meat consumption and advancements in livestock health management are further strengthening demand. Additionally, increasing research activities in immunology and vaccine production contribute to steady market expansion.

Future prospects remain positive with growing investments in biotechnology and life sciences research. Emerging markets are likely to witness increased adoption due to expanding pharmaceutical manufacturing capabilities. Continuous innovation in plasma fractionation technologies and improved quality standards will further enhance market opportunities worldwide.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Product

• Kits And Reagents
• Instruments
• Software And Service

By Technology

• Molecular Diagnostics
• Hematology
• Immunodiagnostics
• Others (Cell culture, etc.)

By Derivative Type

• Immunoglobulin
• Fibrinogen
• Serum Albumin
• Fetal Bovine Serum
• Thrombin
• Transferrin
• Others (BGG, etc)

By Source

• US Grade
• Australia Grade
• New Zealand Grade
• Others

By End-user Industry

• Veterinary Industry
• Food Industry
• Academic And Research Institutes
• Cell Culture/ Biotechnology
• Cosmetic Industry
• Pharmaceutical Industry
• Diagnostics Industry
• Others (Nutrition Supplements, CROs, etc.)

COMPANIES PROFILED

• ANZCO Foods Itoham Yonekyu Holdings, Bovogen Biologicals Pty Ltd ANZCO Foods Healthcare, Moregate Biotech ANZCO Foods, Proliant Health Biologicals, LAMPIRE Biological Laboratories Inc, Rocky Mountain Biologicals, Thermo Fisher Scientific Inc, SigmaAldrich Merck KGaA, Kraeber Co GmbH, Auckland BioSciences Ltd, Lake Immunogenics Inc
• We can customise the report as per your requirements.

TABLE OF CONTENTS

Chapter 1. PREFACE

• 1.1. Market Segmentation & Scope
• 1.2. Market Definition
• 1.3. Information Procurement
  • 1.3.1 Information Analysis
  • 1.3.2 Market Formulation & Data Visualization
  • 1.3.3 Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

• 2.1. Market Snapshot
• 2.2. Segmental Outlook
• 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

• 3.1. Market Lineage Outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Value Chain Analysis
• 3.4. Regulatory Framework
  • 3.4.1 Standards & Compliance
  • 3.4.2 Regulatory Impact Analysis
• 3.5. Market Dynamics
  • 3.5.1 Market Drivers
  • 3.5.2 Market Restraints
  • 3.5.3 Market Opportunities
  • 3.5.4 Market Challenges
• 3.6. Porter's Five Forces Analysis
• 3.7. PESTLE Analysis

Chapter 4. GLOBAL BOVINE BLOOD PLASMA DERIVATIVES MARKET: BY PRODUCT 2022-2034 (USD MN)

• 4.1. Market Analysis, Insights and Forecast Product
• 4.2. Kits And Reagents Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.3. Instruments Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.4. Software And Service Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL BOVINE BLOOD PLASMA DERIVATIVES MARKET: BY TECHNOLOGY 2022-2034 (USD MN)

• 5.1. Market Analysis, Insights and Forecast Technology
• 5.2. Molecular Diagnostics Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.3. Hematology Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.4. Immunodiagnostics Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.5. Others (Cell culture, etc.) Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL BOVINE BLOOD PLASMA DERIVATIVES MARKET: BY DERIVATIVE TYPE 2022-2034 (USD MN)

• 6.1. Market Analysis, Insights and Forecast Derivative Type
• 6.2. Immunoglobulin Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.3. Fibrinogen Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.4. Serum Albumin Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.5. Fetal Bovine Serum Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.6. Thrombin Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.7. Transferrin Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.8. Others (BGG, etc) Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL BOVINE BLOOD PLASMA DERIVATIVES MARKET: BY SOURCE 2022-2034 (USD MN)

• 7.1. Market Analysis, Insights and Forecast Source
• 7.2. US Grade Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.3. Australia Grade Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.4. New Zealand Grade Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.5. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 8. GLOBAL BOVINE BLOOD PLASMA DERIVATIVES MARKET: BY END-USER INDUSTRY 2022-2034 (USD MN)

• 8.1. Market Analysis, Insights and Forecast End-user Industry
• 8.2. Veterinary Industry Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 8.3. Food Industry Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 8.4. Academic And Research Institutes Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 8.5. Cell Culture/ Biotechnology Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 8.6. Cosmetic Industry Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 8.7. Pharmaceutical Industry Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 8.8. Diagnostics Industry Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 8.9. Others (Nutrition Supplements, CROs, etc.) Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 9. GLOBAL BOVINE BLOOD PLASMA DERIVATIVES MARKET: BY REGION 2022-2034(USD MN)

• 9.1. Regional Outlook
• 9.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 9.2.1 By Product
  • 9.2.2 By Technology
  • 9.2.3 By Derivative Type
  • 9.2.4 By Source
  • 9.2.5 By End-user Industry
  • 9.2.6 United States
  • 9.2.7 Canada
  • 9.2.8 Mexico
• 9.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 9.3.1 By Product
  • 9.3.2 By Technology
  • 9.3.3 By Derivative Type
  • 9.3.4 By Source
  • 9.3.5 By End-user Industry
  • 9.3.6 United Kingdom
  • 9.3.7 France
  • 9.3.8 Germany
  • 9.3.9 Italy
  • 9.3.10 Russia
  • 9.3.11 Rest Of Europe
• 9.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 9.4.1 By Product
  • 9.4.2 By Technology
  • 9.4.3 By Derivative Type
  • 9.4.4 By Source
  • 9.4.5 By End-user Industry
  • 9.4.6 India
  • 9.4.7 Japan
  • 9.4.8 South Korea
  • 9.4.9 Australia
  • 9.4.10 South East Asia
  • 9.4.11 Rest Of Asia Pacific
• 9.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 9.5.1 By Product
  • 9.5.2 By Technology
  • 9.5.3 By Derivative Type
  • 9.5.4 By Source
  • 9.5.5 By End-user Industry
  • 9.5.6 Brazil
  • 9.5.7 Argentina
  • 9.5.8 Peru
  • 9.5.9 Chile
  • 9.5.10 South East Asia
  • 9.5.11 Rest of Latin America
• 9.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 9.6.1 By Product
  • 9.6.2 By Technology
  • 9.6.3 By Derivative Type
  • 9.6.4 By Source
  • 9.6.5 By End-user Industry
  • 9.6.6 Saudi Arabia
  • 9.6.7 UAE
  • 9.6.8 Israel
  • 9.6.9 South Africa
  • 9.6.10 Rest of the Middle East And Africa

Chapter 10. COMPETITIVE LANDSCAPE

• 10.1. Recent Developments
• 10.2. Company Categorization
• 10.3. Supply Chain & Channel Partners (based on availability)
• 10.4. Market Share & Positioning Analysis (based on availability)
• 10.5. Vendor Landscape (based on availability)
• 10.6. Strategy Mapping

Chapter 11. COMPANY PROFILES OF GLOBAL BOVINE BLOOD PLASMA DERIVATIVES INDUSTRY

• 11.1. Top Companies Market Share Analysis
• 11.2. Company Profiles
  • 11.2.1 ANZCO Foods (Itoham Yonekyu Holdings)
  • 11.2.2 Bovogen Biologicals Pty Ltd (ANZCO Foods Healthcare)
  • 11.2.3 Moregate Biotech (ANZCO Foods)
  • 11.2.4 Proliant Health & Biologicals
  • 11.2.5 LAMPIRE Biological Laboratories Inc
  • 11.2.6 Rocky Mountain Biologicals
  • 11.2.7 Thermo Fisher Scientific Inc
  • 11.2.8 Sigma-Aldrich (Merck KGaA)
  • 11.2.9 Kraeber & Co GmbH
  • 11.2.10 Auckland BioSciences Ltd
  • 11.2.11 Lake Immunogenics Inc